Roche Holding AG (ROGZ.XC)
Cboe UK - Cboe UK Real-time price. Currency in CHF
Add to watchlist
As of 12:14PM BST. Market open.
| Previous close | 270.05 |
| Open | 271.00 |
| Bid | 272.10 x N/A |
| Ask | 272.20 x N/A |
| Day's range | 270.20 - 272.90 |
| 52-week range | 213.00 - 288.20 |
| Volume | |
| Avg. volume | 188,407 |
| Market cap | 219.414B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 20.57 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 9.60 (3.55%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Zacks
Roche's Lupus Study for Gazyva Meets Primary & Key Secondary Goals
RHHBY announces meeting primary and key secondary goals in the late-stage study of its lymphoma drug, Gazyva/Gazyvaro, for treating active lupus nephritis.
- Zacks
Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea
A federal judge rejected Regeneron's request for a preliminary injunction against Amgen in its lawsuit for Eylea's biosimilar.
- Zacks
Regeneron, SNY's Dupixent Get CHMP Recommendation for Label Expansion
REGN and SNY get positive CHMP opinion on the label expansion of Dupixent in the EU for eosinophilic esophagitis in children down to 1 year of age.
© 2024 Yahoo. All rights reserved.